Stoke Therapeutics Inc (STOK)

Stoke Therapeutics Inc Stock (STOK) Financials Data

*All numbers in millions

Period End Date	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	49.70%9.33	6.23	1.40	10.63	13.82
	25.33%74.75	59.65	62.84	53.72	41.12
Selling, General, and Administrative	26.43%25.25	19.97	21.15	16.03	-
Research and Development	24.77%49.50	39.67	41.70	37.70	25.86
Interest Income/Expense	26.09%0.02	0.02	0.00	0.00	0.00
Operating Income/Loss	22.48%-65.43	-53.42	-61.44	-43.09	-27.30
Nonoperating Income/Loss	11.60%3.81	3.42	3.51	3.47	3.82
Income/Loss From Continuing Operations Before Tax	23.23%-61.62	-50.00	-	-39.63	-23.48
Income Tax Expense/Benefit	-	-	-	-1.28	-
	23.23%-61.62	-50.00	-57.93	-38.35	-23.48
Attributable To Parent	23.23%-61.62	-50.00	-57.93	-38.35	-23.48
Basic Average Shares	4.68%66.02	63.06	-	58.61	58.35
Diluted Average Shares	4.68%66.02	63.06	-	58.61	58.35
Basic Earnings Per Share	17.72%-0.93	-0.79	-	-0.65	-0.40
Diluted Earnings Per Share	17.72%-0.93	-0.79	-	-0.65	-0.40